Anesthetic management of a parturient with hyperhomocysteinemia

Anesthesia and Analgesia

Volumn 106, Issue 6, 2008, Pages 1833-1836

  Luzardo, German E ^a   Karlnoski, Rachel A ^b,c   Williams, Brooke ^a,b   Mangar, Devanand ^a,b   Camporesi, Enrico M ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b TAMPA GENERAL HOSPITAL   (United States)

^c Department of Anesthesiology and Critical Care Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; ENOXAPARIN; FOLIC ACID; HEPARIN; HOMOCYSTEINE; PYRIDOXINE; ANTICOAGULANT AGENT; INHALATION ANESTHETIC AGENT; NITROUS OXIDE;

ADULT; ARTICLE; BLINDNESS; CASE REPORT; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINA VEIN THROMBOSIS; CESAREAN SECTION; CONVALESCENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENETIC ANALYSIS; GESTATIONAL AGE; HUMAN; HYPERHOMOCYSTEINEMIA; LABOR; LABOR INDUCTION; OBSTETRIC ANESTHESIA; PREGNANCY; PRIORITY JOURNAL; SPINAL ANESTHESIA; VEIN THROMBOSIS; BIRTH; BLEEDING; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; DRUG ADMINISTRATION; DRUG EFFECT; LIVE BIRTH; PREGNANCY COMPLICATION;

ADULT; ANESTHESIA, SPINAL; ANESTHETICS, INHALATION; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; CESAREAN SECTION; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HEPARIN; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LIVE BIRTH; NITROUS OXIDE; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 44649127990     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181732655     Document Type: Article

References (33)

1. Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 2007;131: 872- 84
2. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 1996;126: 1285S-9S
3. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003;16:153-68
4. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ III. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year populationbased study. Ann Intern Med 2005;143: 697-706
5. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002; 99:333-41
6. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19:217-46
7. Finkelstein JD, Martin JJ, Harris BJ. Methionine metabolism in mammals. The methionine-sparing effect of cystine. J Biol Chem 1988;263:11750-4
8. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277: 1775-81
9. Hague WM. Homocysteine and pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17:459-69
10. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-59
11. Chesley LC. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 1972;112:440-50
12. Finkelstein JD, Harris BJ, Kyle WE. Methionine metabolism in mammals: kinetic study of betaine-homocysteine methyltransferase. Arch Biochem Biophys 1972;153:320-4
13. Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992;30:377-9
14. Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost 2005;3:949-54
15. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004;126: 627S-644S
16. Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, Priollet P, Cohen C, Yvelin N, Schved JF, Tournaire M, Borg JY. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG 2001;108:1134-40
17. James AH, Grotegut CA, Brancazio LR, Brown H. Thromboembolism in pregnancy: recurrence and its prevention. Semin Perinatol 2007;31:167-75
18. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan C-S. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003;28:172-97
19. Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 2003;349:45-50
20. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 1998;351:36-7
21. Al-Obaidi MK, Stubbs PJ, Collinson P, Conroy R, Graham I, Noble MI. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 2000;36:1217-22
22. Badner NH, Beattie WS, Freeman D, Spence JD. Nitrous oxideinduced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg 2000; 91:1073-9
23. Zanardo V, Caroni G, Burlina A. Higher homocysteine concentrations in women undergoing caesarean section under general anesthesia. Thromb Res 2003;112:33-6
24. Malinow MR, Rajkovic A, Duell PB, Hess DL, Upson BM. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Am J Obstet Gynecol 1998;178:228-33
25. Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP. S-Adenosylmethionine and methylation. FASEB J 1996;10:471-80
26. Hadzic A, Glab K, Sanborn KV, Thys DM. Severe neurologic deficit after nitrous oxide anesthesia. Anesthesiology 1995; 83:863-6
27. Lee P, Smith I, Piesowicz A, Brenton D. Spastic paraparesis after anaesthesia. Lancet 1999;353:554
28. Ahn SC, Brown AW. Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report. Arch Phys Med Rehabil 2005;86:150-3
29. Doran M, Rassam SS, Jones LM, Underhill S. Toxicity after intermittent inhalation of nitrous oxide for analgesia. BMJ 2004;328:1364-5
30. McMorrow AM, Adams RJ, Rubenstein MN. Combined system disease after nitrous oxide anesthesia: a case report. Neurology 1995;45:1224-5
31. Kinsella LJ, Green R. 'Anesthesia paresthetica': nitrous oxideinduced cobalamin deficiency. Neurology 1995;45:1608-10
32. McNeely JK, Buczulinski B, Rosner DR. Severe neurological impairment in an infant after nitrous oxide anesthesia. Anesthesiology 2000;93:1549-50
33. Felmet K, Robins B, Tilford D, Hayflick SJ. Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. J Pediatr 2000;137:427-8